Loading Events

« All Events

  • This event has passed.

Epigenetics in Drug Discovery

26/01/2016 - 27/01/2016

epigenetics in drug discovery

With rapid progress being made in our understanding of epigenetic mechanisms of both new and existing drugs, this SELECTBIO meeting, Epigenetics in Drug Discovery, will explore the potential of epigenetics contribution towards novel and existing therapeutics, across significant areas of unmet need. Emerging technologies, epigenetic changes and cellular reprogramming will be discussed, with special attention to drug discovery and development. Attendees will benefit from expert knowledge of academic and industry leaders pushing the boundaries of epigenetics research, whilst networking with the technology providers who are enabling them to do so.

Confirmed Keynote Speaker:

Rabinder Prinjha, Vice President, GlaxoSmithKline

View the provisional agenda on the website.

You can present your research on a poster while attending the meeting. Poster Submission Deadline: 19 January 2016.

Contact for more information:

Sara Spencer

s.spencer@selectbio.com

Tel: +44 (0) 1787 314956

Details

Start:
26/01/2016
End:
27/01/2016

Venue

Buckingham House
Cambridge, United Kingdom + Google Map

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.